Deepthi Rajan, PA
Adult Medicine · Lincoln Park, MINPI 1548045560
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Among adult medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$203
- Lilly USA, LLC$124
- Otsuka America Pharmaceutical, Inc.$96
- AbbVie$95
- GSK$56
- Orexo US, Inc.$46
- plus $378 from 12 others
What the payments were for
- Food & beverage$999100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 8 | $203 |
| Lilly USA, LLC | 7 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| AbbVie | 4 | $95 |
| GSK | 3 | $56 |
| Orexo US, Inc. | 3 | $46 |
| Pfizer | 2 | $44 |
| Neurelis, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Exact Sciences | 2 | $40 |
| AstraZeneca | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Viatris Specialty LLC | 1 | $32 |
| Mannkind Corporation | 1 | $29 |
| Merck | 1 | $24 |
| Novo Nordisk | 1 | $21 |
| Indivior Inc. | 1 | $16 |
| Novartis | 1 | $14 |
How this compares
$999 in reported general payments places this provider in the 95th percentile of 23 adult medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 53 | $36,030 |
| OzempicSemaglutide | 20 | $19,388 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $19,071 |
| TrulicityDulaglutide | 14 | $18,708 |
| FarxigaDapagliflozin Propanediol | 21 | $15,418 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 72 | $15,138 |
| JardianceEmpagliflozin | 16 | $14,090 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $11,854 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,920 |
| LinzessLinaclotide | 16 | $8,843 |
| Fenofibrate | 26 | $4,585 |
| Varenicline Tartrate | 11 | $4,331 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 117 | $3,679 |
| PremarinEstrogens, Conjugated | 11 | $2,288 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $2,251 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin | $44 | $38,31864 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $38 | $24,33835 claims |
| Novo NordiskOzempic | $21 | $19,38820 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $124 | $19,22548 claims |
| GSKTrelegy Ellipta | $56 | $19,07128 claims |
| Indivior Inc.Suboxone | $16 | $11,85415 claims |
| AbbVieLinzess | $95 | $8,84316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 23 adult medicine providers in Michigan.
Other adult medicine in Lincoln Park
- Joseph GeorgeLincoln Park$485
- Mohammadreza KahnamoueiClinton Township$4K
- Dawn SpringerMason$749
- Michael YardIron River$431
- Colin OrrinMadison Heights$430
- Jordan DemchukLansing$400
- David VanwinkleMuskegon$210
- Rakesh SoniWayne$189
- Courtney MorganGrand Haven$172
- Sarah YoungNorton Shores$120
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.